Justifications for discrepancy in dissolution vs. BE study [Dissolution / BCS / IVIVC]

posted by Helmut Homepage – Vienna, Austria, 2014-04-10 14:31 (4454 d 14:53 ago) – Posting: # 12805
Views: 6,161

Hi gtomer,

in vivo BE overrules any in vitro dissimilarity (as a successful therapeutic equivalence study would over­rule in vivo inequivalence). You should perform the comparative dissolution, but demonstrating in vitro similarity is not necessary. See also this thread.

❝ Does anyone know of any investigatory methods or justifications found for such discrepancy, i.e. where reference vs. test found similar in BE study but F2>50 in dissolution?


I guess you mean ƒ2 <50? Either the dissolution media are not biorelevant (i.e., overdiscriminatory, since BE was proven in vivo) or dissolution is not the driving force for absorption at all (e.g., BCS classes I/IV).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
153 visitors (0 registered, 153 guests [including 35 identified bots]).
Forum time: 05:24 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5